DBMR - Medical Devices

North America Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Sep 2019
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

North America Active Pharmaceutical Ingredients (API) Market By Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturers, Merchant API Manufacturers), Type of Synthesis (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Type of Drug (Prescription Drugs, Over-The-Counter Drugs), Therapeutic Application (Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Other Therapeutic Applications), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2026

Market Analysis: North America Active Pharmaceutical Ingredients (API) Market

North America active pharmaceutical ingredients (API) market is registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed due to the surging incidences of chronic diseases and various technological innovations in API manufacturing which is contributing to the growth of the market

Market Definition: North America Active Pharmaceutical Ingredients (API) Market

There has been surge in the elderly population which is driving the need for the drugs. Active pharmaceutical ingredient (API) is the component of any drug that generates its effect. Some drugs, such as combination therapy, have various effective components to cure distinct diseases or to behave in distinct respects. Generally, the pharmaceutical companies themselves have produced APIs in their respective nations. But in latest years, many corporations have chosen to ship manufacturing abroad to reduce expenses. This has led to important modifications in the way these drugs are controlled, with more strict guidance and checks in location.There are various companies which have started their own business line in API manufacturing with the rising need for drugs.

Market Drivers

  • Rising prevalence of chronic diseases is driving the growth of the market
  • Innovations in API Manufacturing is propelling the growth of the market
  • Rise in the elderly population is boosting the growth of the market
  • The rise in the adoption of artificial intelligence-based drug discovery instruments is contributing to the growth of the market

Market Restraints

  • Drug costs monitoring strategies throughout countries is hampering the growth of the market
  • Heavy competition among the players in the market of API is hindering the growth of the market
  • The rising advancements in anti-counterfeit drugs is restricting the growth of the market

Segmentation: North America Active Pharmaceutical Ingredients (API) Market

By Type

  • Innovative Active Pharmaceutical Ingredients
  • Generic Active Pharmaceutical Ingredients

By Type of Manufacturer

  • Captive API Manufacturers
  • Merchant API Manufacturers

    • By Type

      • Merchant Innovative API Manufacturers
      • Merchant Generic API Manufacturers

    • By Type of Synthesis

      • Merchant Synthetic API Manufacturers
      • Merchant Biotech API Manufacturers

By Type of Synthesis

  • Synthetic Active Pharmaceutical Ingredients

    • Innovative Synthetic APIS
    • Generic Synthetic APIS

  • Biotech Active Pharmaceutical Ingredients    

    • BY type

      • Innovative Biotech APIS
      • Generic Biotech APIS

    • By product

      • Monoclonal Antibodies
      • Hormones & Growth Factors
      • Cytokines
      • Fusion Proteins
      • Recombinant Vaccines
      • Therapeutic Enzymes
      • Blood Factors

    • By Expression System

      • Mammalian Expression Systems
      • Microbial Expression Systems
      • Yeast Expression Systems
      • Insect Expression Systems
      • Other Expression Systems

By Type of Drug

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Potency

    • Low-To-Moderate Potency Active Pharmaceutical Ingredients
    • Potent-To-Highly Potent Active Pharmaceutical Ingredient

By Therapeutic Application

  • Communicable Diseases
  • Oncology
  • Pain Management
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Other Therapeutic Application

By Country

  • U.S.
  • Canada
  • Mexico

Key Developments in the Market:

  • In October 2018, SEPPIC had launched TECA Pharma which is an active pharmaceutical ingredient. It has broad application in venous insufficiency and wound healing. The launch had helped various customers in the product development process.
  • In April 2016, HUMCO had launched twenty-four repackaged Active Pharmaceutical Ingredients in the various segments such as infectious disease, pain management and hormone replacement therapy. It allows the enhanced quality for the hospitals and pharmacies. The launch will expand the portfolio of the company and bring value to the patients.

Competitive Analysis:

North America active pharmaceutical ingredients (API) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of active pharmaceutical ingredients (API) market for U.S., Canada and Mexico.

Key Market Competitors:

Few of the major market competitors currently working in the North America active pharmaceutical ingredients (API) market are Pfizer Inc., Novartis AG, Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., GlaxoSmithKline plc., Merck Sharp & Dohme Corp., AbbVie Inc., AstraZeneca, Aurobindo Pharma, BASF SE, Dr. Reddy’s Laboratories Ltd., LUPIN., Mylan N.V., Sun Pharmaceutical Industries Ltd, Piramal Pharma Solutions, Sandoz International GmbH, Saneca Pharmaceuticals a. s and others.

Research Methodology:  North America Active Pharmaceutical Ingredients (API) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of North America active pharmaceutical ingredients (API) market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART